The global ambulatory infusion pumps market size was USD XX billion in 2022 and is likely to reach USD XX billion by 2031, expanding at a CAGR of XX % during 2023–2031. The market growth is attributed to the rising cases of chronic disease across the world.
Ambulatory infusion pumps market is driven by its rising demand among the geriatric population that requires home treatment. As the home-setting treatments are cost-effective and comfortable, they adopt ambulatory infusion pumps. Moreover, the surging use of ambulatory infusion pumps for the delivery of drugs in various conditions and diseases is further boosting the market. For Instance,
- As per a report published by the National Institute of Health, the median age of cancer diagnosis of people in the US is 66 years. Whereas, 72 years is the median age of death among people with different cancer types including breast cancer, prostate cancer, and lung & bronchus cancer being the most common. This factor increases the demand for infusion pumps among old-aged people.
Many patients and medical experts suggest using infusion pumps as they have high-drug delivering efficacy, that offers positive patient results. Additionally, these pumps provide drug dosage according to the specific time settings in the system. thus, it becomes easy for patients to safely monitor the infusion amount in ambulatory pumps, which in turn propels the global market.
The research report finds that the COVID-19 pandemic affected the ambulatory infusion pumps market, due to the rising incidence of COVID cases across the world. Thus, there was a decreased amount of demand for new infusion pumps. However, patients with existing chronic conditions had a considerable demand for infusion pumps, due to the rising home-care setups. This helped in the recovery of the market during the pandemic.
Ambulatory Infusion Pumps Market Dynamics
Major Drivers
Increasing number of chronic diseases across the world is boosting the market. Several diseases and treatments such as chemotherapy, insulin, and antibiotics require assisted ambulatory drug-delivering systems to effectively offer drugs to the patients, thus they are highly adopted by healthcare professionals and patients. Additionally, old people have a high occurrence of chronic diseases which increases their demand for various drug-delivery infusion pumps, , which in turn fuels the market. For instance,
-
On May 19, 2023, the UN News published a report, that states that according to the World Health Organization (WHO), the total number of global deaths caused due to various health conditions is around 90 million. In this total number, 86% of deaths are likely to be caused due to chronic conditions which include cancer, cardiovascular diseases, respiratory illnesses, and diabetes.
Existing Restraints
High costs associated with the infusion pump systems are expected to affect the market growth, as patients with regular hospitalization have limited healthcare investment. Additionally, side effects associated with the systems such as software problems, the inefficacy of results, alarm errors, and battery failures impede the demand for ambulatory infusion pumps, which in turn affects the market growth.
Emerging Opportunities
Technological advancements in ambulatory infusion pump systems are expected to create lucrative revenue generation opportunities for the key players in the market. Rising incidences of chronic health conditions among people due to various reasons such as lack of physical exercise, environmental factors, and individual risk factors increase the demand for clinical research and thus create high growth opportunities in the market.
Scope of Ambulatory Infusion Pumps Market Report
The report includes an assessment of trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Ambulatory Infusion Pumps Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Devices, Accessories, Consumables, and Others), Usage (Disposable and Reusable), Administration Route (Subcutaneous, Intravenous, Epidural, and Others), Application (Emergency Medicine, Oncology, General Anesthesia, Gastroenterology, Pain Management, Neonatology, Diabetes, and Others), and End-user (Hospitals, Ambulatory Surgical Centers, Home Care Settings, Specialty Clinics, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
ICU Medical Inc.; Micrel Medical Devices SA; KORU Medical Systems; WalkMed; Baxter; Eitan Medical; Medtronic; Fresenius Kabi AG; Moog Inc.; and Ace-medical.
|
Ambulatory Infusion Pumps Market Segment Insights
Product Segment Analysis
Based on product, the ambulatory infusion pumps market is divided into devices, accessories, consumables, and others. The devices segment is expected to expand at a major growth rate during the projection period, as they are an integral system that stores the dosage information and delivers an adequate amount of drug to the patient. Additionally, infusion devices help in providing nutrients in an organized manner, which further propels the segment.
The accessories segment is anticipated to account for a significant market share during the forecast period, as different accessories help to deliver medicines to the administration site. In addition, accessories such as syringe infusion pumps are capable of withdrawing or infusing fluids in small amounts as per patient requirements. These characteristics of the infusion pump accessories help in fueling the market.
Usage Segment Analysis
On the basis of usage, the global market is segregated into disposable and reusable. The disposable segment is projected to register a considerable CAGR during the forecast period, as it reduces the chance of infection spread between the patient and the caretaker or doctor. One-time-use infusion pumps come in untouched and bacteria-resistant packaging, which ensures that the patient is safe from contracting any potential disease from external bacteria. These factors have increased the use of disposable pumps which is propelling the growth of the market.
The reusable segment accounts for a significant market share, as it is a cost-effective option and reduces the frequency of purchasing new products. Moreover, it is a sustainable option for infusion pumps as it reduces the amount of packaging material and product waste. These factors are likely to fuel the segment in the coming years.
Administration Route Segment Analysis
On the basis of administration route, the ambulatory infusion pumps market is segmented into subcutaneous, intravenous, epidural, and others. The epidural segment is expected to register a robust growth rate during the projection period, as it helps to ease the pain of the patient, by maintaining analgesia during labor. This route helps to reduce surgical stress response and recurring cancer risks. These factors are likely to propel the segment's growth in the market.
The subcutaneous segment is expected to hold a significant share of the market, as small-sized needles help to reduce pain during infusion. Additionally, this route is less expensive and convenient as compared to intravascular injection and administration, which helps in segment growth during the forecast period.
Application Segment Analysis
Based on application, the ambulatory infusion pumps market is divided into emergency medicine, oncology, general anesthesia, gastroenterology, pain management, neonatology, diabetes, and others. The diabetes segment is expected to expand at a major growth rate during the projection period, as infusion pumps ideally help in delivering insulin in an organized manner. This ensures patient safety and has increased the use of infusion pumps for diabetic patients, which in turn, boosts the market.
The oncology segment is anticipated to account for a significant market share during the forecast period, attributing to the rising cancer cases across the world. Ambulatory drug infusion pumps are vital in chemotherapy to provide anti-cancer drugs, this drives the segment. For instance,
-
As per a report published by the World Health Organization (WHO) on February 3, 2022, cancer is one of the leading causes of increasing mortality rates, which accounts for about 10 million deaths in the year 2020.
End-user Segment Analysis
On the basis of end-user, the ambulatory infusion pumps market is segmented into hospitals, ambulatory surgical centers, home care settings, specialty clinics, and others. The ambulatory surgical centers segment is expected to register a robust growth rate during the projection period, due to an extensive demand for ambulatory infusion pumps for drug delivery. Moreover, the presence of highly skilled experts in ambulatory surgical centers to operate infusion pumps propels the segment in the coming years.
The home care settings segment is expected to hold a significant share of the market, due to the rising need for convenient and comfortable setups among patients. Old-aged people require ambulatory infusion pumps to avoid extended stays in the hospitals, as they might contract other hospital-acquired diseases. Furthermore, as geriatric people require consistent monitoring, they are highly adopting infusion pumps.
Regional Outlook
In terms of region, the global ambulatory infusion pumps market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, as the region has a rising number of acute and chronic condition cases. In addition, the healthcare infrastructure in the region is growing at a high rate, which further aids the regional market growth. Furthermore, strategic alliances among the leading key players are further driving the healthcare system, which is boosting the market in the region.
The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to the rising number of chronic cases including cancer, diabetes, and cardiovascular conditions. This rising income for drug infusion pumps among a large pool of patients is driving the regional market. For instance,
- According to a report published on February 10, 2022, by the Ministry of Science and Technology of the Government of India, with over 77 million diabetic patients, India is known to have a high diabetic population across the globe. Additionally, the report also states that this number is expected to reach around 134 million by 2045.
Segments
The ambulatory infusion pumps market has been segmented on the basis of
Product
- Devices
- Accessories
- Consumables
- Others
Usage
Administration Route
- Subcutaneous
- Intravenous
- Epidural
- Others
Application
- Emergency Medicine
- Oncology
- General Anesthesia
- Gastroenterology
- Pain Management
- Neonatology
- Diabetes
- Others
End-user
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Specialty Clinics
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players operating in the global ambulatory infusion pumps market include ICU Medical Inc.; Micrel Medical Devices SA; KORU Medical Systems; WalkMed; Baxter; Eitan Medical; Medtronic; Fresenius Kabi AG; Moog Inc.; and Ace-medical
Major companies are adopting market expansion & growth strategies such as acquisitions, divestitures, partnerships, R&D investments, collaboration, mergers, and product launches to boost their market share. For instance,
- On August 29, 2023, ICU Medical Inc., a leading medical device development and manufacturing company, received a clearance from the FDA for LifeShield Infusion Safety Software and Plum Duo Infusion Pump. The company stated that this product and software service will be available in the US from 2024.
Request For Customization
Enquiry Before Buying
Speak With Analyst
